Jonathan D. Black

T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2

Roberta Nicoletti, Salvatore Lopez, Stefania Bellone et al. · Clinical & Experimental Metastasis · 2014 · 68 citations · Full text

Medicine, Oncology, Pharmacology +13

A Series of Malignant Ovarian Cancers Arising From Within a Mature Cystic Teratoma

Jonathan D. Black, Dana M. Roque, Monica C. Pasternak et al. · International Journal of Gynecological Cancer · 2015 · 40 citations

Medicine, Oncology, Surgery +17

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

Jonathan D. Black, Salvatore Lopez, Emiliano Cocco et al. · British Journal of Cancer · 2015 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dual-Targeting Nanoparticles for <i>In Vivo</i> Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

Emiliano Cocco, Yang Deng, Erik M. Shapiro et al. · Molecular Cancer Therapeutics · 2016 · 37 citations · Full text

Pharmacy, Molecular Biology, Oncology +17

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

Stefania Bellone, Renata Tassi, Marta Betti et al. · British Journal of Cancer · 2013 · 31 citations · Full text

Medicine, Immunology, Oncology +17